Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Pediatric Clinical Trials Market Be Worth By 2029?
In the past few years, the market size for pediatric clinical trials has seen robust growth. The market is anticipated to expand from $17.41 billion in 2024 to $18.38 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.6%. This growth during the historic period is due to several factors such as regulatory incentives, unfulfilled medical needs, progress in pediatric medicine, global health initiatives, ethical requirements, and pediatric immunization programs.
Expectations are high for a substantial expansion in the pediatric clinical trials market size in the forthcoming years. The market will likely rise to $24.64 billion by 2029 with a compound annual growth rate (CAGR) of 7.6%. This projected growth within the forecast period can be credited to the incorporation of real-world evidence, the discovery of pediatric biomarkers, the establishment of expanded access programs, research into pediatric infectious diseases, and advancements in pediatric cardiology. Significant forecast period trends encompass patient-focused trial design, the embrace of adaptive trial strategies, the use of digital health technologies, global partnerships, and alliances, and progression in pediatric oncology.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10350&type=smp
Which Key Factors Are Fueling Growth In The Pediatric Clinical Trials Market?
The surge in cases of cancer among children is predicted to drive the market for pediatric clinical trials forward. Pediatric cancer is defined as cancer that occurs in kids and teenagers under 14 years. Such cancers are quite rare and the way they grow and spread may be different from the patterns found in adult tumors. Pediatric clinical trials have repeatedly proven crucial to the progression of our understanding and treatment options. For instance, the American Cancer Society, a voluntary health organization based in the US, forecasts in January 2023 that around 9,910 American children aged less than 15 will receive a cancer diagnosis. They also expect about 1,040 children of the same age group to die of cancer in 2023. Consequently, the increasing investment in healthcare is fueling the market for pediatric clinical trials.
Which Segmentation Factors Are Critical In The Pediatric Clinical Trials Market Analysis?
The pediatric clinical trialsmarket covered in this report is segmented –
1) By Phase: Phase I; Phase II; Phase III; Phase IV
2) By Study Design: Treatment Studies; Observational Studies
3) By Therapeutic Areas: Infectious Diseases; Oncology; Autoimmune Or Inflammatory Diseases; Respiratory Disorders; Mental Health Disorders; Other Therapeutic Areas
Subsegments:
1) By Phase I: First-in-Pediatrics Trials; Dose Escalation Studies; Safety And Tolerability Assessments
2) By Phase II: Efficacy Studies; Dose Optimization Trials; Pharmacokinetic Studies
3) By Phase III: Large-Scale Efficacy Trials; Comparative Studies; Long-Term Safety Studies
4) By Phase IV: Post-Marketing Surveillance; Long-Term Safety Monitoring; Effectiveness Studies In Real-World Settings
What Are The Dominant Trends Currently Seen In The Pediatric Clinical Trials Market?
The enhancement of products via innovation is a notable trend emerging in the pediatric clinical trial industry. Businesses in the pediatric clinical trials arena are exploiting novel, inventive solutions to retain their market superiority. To illustrate, The Leukemia & Lymphoma Society, an American voluntary health institution, initiated the Pediatric Acute Leukemia (PedAL) Master Clinical Trial in June 2022. It’s a specialized clinical trial for pediatric acute leukemia where each child’s distinct tumor biology is determined to assist in aligning them with the most suitable treatment.
Which Players Are Shaping The Competitive Landscape Of The Pediatric Clinical Trials Market?
Major companies operating in the pediatric clinical trials market include Medpac Inc., Pharmaceutical Product Development Inc., ICON plc, Syneos Health Inc., QPS Holdings LLC, Pfizer Inc., IQVIA Inc., Premier Research, Labcorp – Laboratory Corporation of America Holdings, The Emmes Company LLC, Synteract Inc., Charles River Laboratories International Inc., Covance Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, BioNTech SE, Moderna Inc., Parexel International Corporation, PRA Health Sciences, Wuxi AppTec, Merck & Co. Inc., AstraZeneca plc, Sanofi S.A., Johnson & Johnson, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, C.H. Boehringer Sohn AG & Co. KG, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Oracle Health sciences
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/pediatric-clinical-trials-global-market-report
Which Region Is Likely To Register The Fastest Growth In The Pediatric Clinical Trials Market?
North America was the largest region in the pediatric clinical trials market in 2024. The regions covered in the pediatric clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=10350&type=smp
Browse Through More Reports Similar to the Global Pediatric Clinical Trials Market 2025, By The Business Research Company
Pediatric Vaccine Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report
Pediatric Dental Crown Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pediatric-dental-crown-global-market-report
Pediatric Imaging Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pediatric-imaging-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model